Dr. Timothy Smith 2 | National Headache Foundation

Certificate of Added Qualification in Headache Medicine (AQH)

January 2021, Episode 83: Dr. Lindsay Weitzel and Dr. Timothy Smith discuss the National Headache Foundation’s Certificate of Added Qualification in Headache Medicine (AQH). The program was started in 2000 in direct response to requests from people living with migraine…

Study Data on Psilocybin and Treatment for Migraine

January 2021, Episode 81: Researchers out of Yale just published a small study on the use of psilocybin in a group of patients with migraine. Survey data and anecdotal reports have previously shown psilocybin to be helpful in cluster headache….

Medical Update on Nocira

November 2020, Episode 78: Dr. Lindsay Weitzel talks with Dr. Tim Smith about Nocira, the latest device being trialed for migraine treatment. This interesting device works with your smartphone and utilizes puffs of air into your ear through what look…

Medical Update on Nerivio

October 2020, Episode 75: Dr. Lindsay Weitzel welcomes back Dr. Timothy Smith to Heads UP to discuss the real-world data recently released on Nerivio as a treatment for migraine disease. Nerivio is a wireless remote electrical neuromodulation device for the…

Medical Update – VYEPTI

September 2020, Episode 72: Medication Update – Lundebeck has issued a press release on their latest migraine medication – Vyepti. It is great news for those of us living with migraine disease. Dr. Tim Smith and Dr. Lindsay Weitzel discuss…

Botox, Migraine Disease, and Pregnancy

September 2020, Episode 71: Botox is not indicated for use in pregnancy. This puts many women who are prescribed Botox for chronic migraine in a difficult position when it comes time for them to start a family. Data has just…

Devices to Treat Migraine Disease and Cluster Headache

August 2020, Episode 70: Many people like to include devices in their treatment plans because they are non-invasive and have low side-effect profiles. In this week’s episode of Heads Up, Dr. Tim Smith and Dr. Lindsay Weitzel discuss and demonstrate…

New Drug Data Alert – Atogepant

August 2020, Episode 69: New data was revealed this month on the upcoming gepant indicated for migraine prevention called Atogepant. Dr. Lindsay Weitzel questions Dr. Tim Smith about its safety and effectiveness. How will we take it and how often?…

New and Emerging Migraine Therapies, Pt. 2

January 2020, Episode 44: Dr. Timothy Smith and Dr. Lindsay Weitzel compare and contrast three oral gepants, an IV monoclonal antibody, two combination therapies, and an anti-inflammatory agent – all expected to be available for the treatment of migraine in…

‹ Previous